• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. GlaxoSmithKline Global Pharmaceuticals President Abbas Hussain to Leave -- Update

    GlaxoSmithKline Global Pharmaceuticals President Abbas Hussain to Leave -- Update

  2. Drug Delivery Technology Market by Route of Administration & Patient Care Setting - Global Forecast to 2021 - Research and Markets

    Drug Delivery Technology Market by Route of Administration & Patient Care Setting - Global Forecast to 2021 - Research and Markets

  3. Chi-Med appoints Industry Veteran Paul Carter to Board of Directors

    Chi-Med appoints Industry Veteran Paul Carter to Board of Directors

  4. UPDATE: Drug makers, auto stocks yank European stocks lower for first time in 3 days

    UPDATE: Drug makers, auto stocks yank European stocks lower for first time in 3 days

  5. EUROPE MARKETS: Drug Makers Struggle, Pulling European Markets Lower

    EUROPE MARKETS: Drug Makers Struggle, Pulling European Markets Lower

  6. UPDATE: Drug makers struggle, pulling European markets lower

    UPDATE: Drug makers struggle, pulling European markets lower

  7. LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

    LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

  8. UPDATE: FTSE 100 logs 10th day of all-time highs

    UPDATE: FTSE 100 logs 10th day of all-time highs

  9. $85.4 Billion Monoclonal Antibodies (mAbs) Market Analysis By Source, By Type of Production, By Indication, By End-use And Segment Forecasts, 2013 - 2024 - Research and Markets

    $85.4 Billion Monoclonal Antibodies (mAbs) Market Analysis By Source, By Type of Production, By Indication, By End-use And Segment Forecasts, 2013 - 2024 - Research and Markets

  10. Teva Settles Charges in U.S. -- WSJ

    Teva Settles Charges in U.S. -- WSJ

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.